Argenica Therapeutics Share Price and Company Fundamentals
Last traded: Last Friday at 6:10 AM
Argenica Therapeutics Limited researches and develops a neuroprotective therapeutic drug in Australia. Its lead product candidate is ARG007, a neuroprotective peptide candidate in pre-clinical trials for use in the protection of brain tissue against damage during a stroke. The company was incorporated in 2019 and is based in Nedlands, Australia.
|Primary activities||Development and commercialisation of a novel therapeutic|
|Industry / Sector||Biotechnology / Healthcare|
|Mailing address||29 The Avenue Suite 2 Nedlands WA 6009 Australia|
|Phone / Fax||61 8 9329 3396 /|
|Share registry||LINK MARKET SERVICES LIMITED|
Argenica Therapeutics does not pay dividends.
As of Jun 2021, following are the company executives and directors listed on Argenica Therapeutics.
Profitability and management effectiveness
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Argenica Therapeutics is and its enterprise value is 19.02M.
Companies similar to Argenica Therapeutics (AGN)
Argenica Therapeutics (ASX:AGN) Frequently Asked Questions
1. What is Argenica Therapeutics's Stock Symbol?
Argenica Therapeutics trades on ASX under the ticker symbol "AGN".
2. What is Argenica Therapeutics's stock price today?
One share of AGN stock can currently be purchased for approximately $0.26.
3. How can I contact Argenica Therapeutics?
Argenica Therapeutics's mailing address is 29 The Avenue Suite 2 Nedlands WA 6009 Australia. The company can be reached via phone at 61 8 9329 3396.
4. What is Argenica Therapeutics's official website?
The official website of Argenica Therapeutics is http://www.argenica.com.au.
5. Which share registry manages Argenica Therapeutics's stock?
Argenica Therapeutics's stock is managed by LINK MARKET SERVICES LIMITED.